WallStSmart
PALI

Palisade Bio Inc

NASDAQ: PALI · HEALTHCARE · BIOTECHNOLOGY

$2.00
+3.63% today

Updated 2026-04-30

Market cap
$328.54M
P/E ratio
P/S ratio
11.78x
EPS (TTM)
$-0.30
Dividend yield
52W range
$1 – $3
Volume
4.1M

Palisade Bio Inc (PALI) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-3.33M$-4.00M$-6.86M$-5.14M$-9.98M$-8.10M$-8.48M$-10.59M$-11.71M$-18.93M$-15.62M$-13.42M$-7.69M$-7.26M$-4.77M$-14.77M$-13.36M$-11.13M$-12.19M$-10.85M
Capital expenditures$59212.00$229627.00$193630.00$210784.00$332675.00$480850.00$254858.00$537050.00$556348.00$243584.00$161114.00$94046.00$1714.00$6000.00$6000.00$0.00$10000.00$4000.00$0.00$0.00
Depreciation$51923.00$32056.00$65761.00$88664.00$130752.00$187050.00$211143.00$244725.00$348630.00$345460.00$337508.00$289208.00$185803.00$143859.00$3000.00$2000.00$3000.00$4000.00$3000.00
Stock-based comp$359929.00$1.58M$4.63M$4.56M$5.24M$3.33M$1.61M$2.33M$4.32M$2.95M$3.45M$1.77M$1.09M$3.33M$2.01M$1.89M$1.03M$624000.00$652000.00$3.96M
Free cash flow$-3.39M$-4.23M$-7.05M$-5.36M$-10.31M$-8.58M$-8.73M$-11.13M$-12.26M$-19.18M$-15.78M$-13.51M$-7.69M$-7.26M$-4.77M$-14.77M$-13.37M$-11.14M$-12.19M$-10.85M
Investing cash flow$-59212.00$-229627.00$-193630.00$-332675.00$-480850.00$-254858.00$-537050.00$-15.56M$7.25M$2.36M$-94046.00$5.00M$3.92M$-6000.00$-54000.00$-10000.00$-4000.00
Financing cash flow$4.67M$9.83M$4.55M$2.76M$17.27M$1.67M$13.82M$20.52M$22.94M$3.89M$23.74M$4.99M$1.81M$6.59M$1.89M$24.61M$15.26M$11.19M$9.58M
Dividends paid$99000.00
Share repurchases
Debt repayment
Net change in cash